gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.
about
Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopesStructure-based design of altered MHC class II-restricted peptide ligands with heterogeneous immunogenicityClonal expansions of 6-thioguanine resistant T lymphocytes in the blood and tumor of melanoma patientsMHC class II presentation of gp100 epitopes in melanoma cells requires the function of conventional endosomes and is influenced by melanosomes.Circulating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer Patients.DC expressing transgene Foxp3 are regulatory APC.Enhancement in specific CD8+ T cell recognition of EphA2+ tumors in vitro and in vivo after treatment with ligand agonists.Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanomaIL-7- and IL-15-mediated TCR sensitization enables T cell responses to self-antigens.In vitro induction of myeloid leukemia-specific CD4 and CD8 T cells by CD40 ligand-activated B cells gene modified to express primary granule proteinsLocoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus interleukin-2: induction of autologous tumor-reactive CD4+ Th1 killer lymphocytes.Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.Insights into the Role of GILT in HLA Class II Antigen Processing and Presentation by Melanoma.A novel splice variant of Pmel17 expressed by human melanocytes and melanoma cells lacking some of the internal repeats.Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets.
P2860
Q24674180-582344C7-658F-48CC-B22F-C1A11629FD3DQ27680213-66BBA3C2-4F1D-453D-B7CD-4ED6B4AF5FBCQ28742878-3D662765-2DF7-4BF5-BC15-8C3C5555446DQ30437794-9383B002-9489-4DE8-822D-CD702E590FB4Q34259974-3A646D25-D4B7-40BE-ADE6-AAB004BDE30AQ34503547-8BDE37EB-807E-4A60-B3B8-091A48D06E82Q36190047-291CBB73-6A1D-432A-AE75-DF5714391378Q36371068-2E9BB552-3A28-43CC-A881-2C1C238AD757Q36616642-7E83778F-36F4-499C-A9FA-168503055FECQ36628925-38195640-204D-4479-A01C-0ED28906DE22Q36671598-FA15F523-7814-4C2E-BDA0-BA6683220F58Q36696205-3FFBED5A-8DCA-4D2C-8555-A03EB046EE4EQ37474050-E287A1F0-8757-48AE-8F24-0E4ED74E9F66Q37476322-07426556-B164-4D21-83B9-E145F43AF953Q38208309-7B49A856-549B-44E5-843A-F1BD12194C7C
P2860
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.
@ast
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.
@en
type
label
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.
@ast
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.
@en
prefLabel
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.
@ast
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.
@en
P2093
P2860
P356
P1476
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.
@en
P2093
C L Slingluff
J M Kirkwood
L S Kierstead
W J Storkus
Y L Kasamon
P2860
P2888
P304
P356
10.1054/BJOC.2001.2160
P407
P577
2001-11-01T00:00:00Z
P5875
P6179
1049735170